Leerink Partners Cuts Price Target on Imprivata (IMPR) Following 3Q Pre-Announcement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
William Blair Downgrades Imprivata (IMPR) to Market Perform
October 15, 2015 7:59 AM EDTWilliam Blair downgraded Imprivata (NYSE: IMPR) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.
Shares of Imprivata closed at $17.31 yesterday.
... MoreJPMorgan Downgrades Imprivata (IMPR) to Neutral
October 15, 2015 7:58 AM EDTJPMorgan downgraded Imprivata (NYSE: IMPR) from Overweight to Neutral with a price target of $19.00 (from $24.00).
For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.
Shares of Imprivata closed at $17.31 yesterday.
... MoreAfter-Hours Movers 10/14: (DXCM) (MBI) (XNLX) Higher; (IMPR) (HCA) (NFLX) Lower (more...)
October 14, 2015 6:14 PM EDTImprivata (NYSE: IMPR) 25.6% LOWER; announced preliminary results for three months ended September 30, 2015. Sees revenues $28.9m-$29.2m and Non-GAAP Loss Per Share $(.23)-$(.22). (Street sees Q3 loss per share of 20 cents on revenue of $31.4 million)
DexCom, Inc. (Nasdaq: DXCM) 14% HIGHER; Reported preliminary unaudited revenues of approximately $105 million for the quarter ended September 30, 2015, an increase of $36 million, or 52%, year over year. Dexcoms third quarter 2015 revenues are preliminary and subject to adjustment as the Company evaluates the... More
Imprivata (IMPR) Reports Below Consensus Preliminary Q3 EPS
October 14, 2015 4:20 PM EDTImprivata (NYSE: IMPR), the healthcare IT security company, today announced preliminary results for three months ended September 30, 2015.
Preliminary Third Quarter 2015... More
